MLICM
IMVT icon

Metropolitan Life Insurance Company (MetLife)’s Immunovant IMVT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,955
Closed -$95.5K – 1027
2024
Q1 		$95.5K Sell
2,955
-163
-5% -$5.95K ﹤0.01% 1066
2023
Q4 		$131K Hold
3,118
– – 0.01% 939
2023
Q3 		$120K Buy
3,118
+167
+6% +$3.77K 0.01% 916
2023
Q2 		$56K Buy
2,951
+585
+25% +$10.9K ﹤0.01% 1359
2023
Q1 		$36.7K Sell
2,366
-388
-14% -$6.73K ﹤0.01% 1560
2022
Q4 		$48.9K Buy
2,754
+299
+12% +$3.77K ﹤0.01% 1494
2022
Q3 		$13.7K Buy
+2,455
New +$12K ﹤0.01% 2193
2022
Q2 		– Sell
-2,758
Closed -$15.2K – 2399
2022
Q1 		$15.2K Sell
2,758
-1,238
-31% -$7.71K ﹤0.01% 2203
2021
Q4 		$34K Sell
3,996
-1,409
-26% -$11.6K ﹤0.01% 2728
2021
Q3 		$47K Sell
5,405
-6,840
-56% -$61.7K ﹤0.01% 2768
2021
Q2 		$129K Buy
12,245
+2,885
+31% +$40.3K ﹤0.01% 2450
2021
Q1 		$150K Sell
9,360
-943
-9% -$24.9K ﹤0.01% 2209
2020
Q4 		$476K Hold
10,303
– – 0.01% 1384
2020
Q3 		$363K Buy
10,303
+3,779
+58% +$114K 0.01% 1428
2020
Q2 		$159K Buy
+6,524
New +$140K ﹤0.01% 1960

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s IMVT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Immunovant (IMVT) in Q2 2024, closing a stake of 2,955 shares — an estimated $95.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in IMVT in Q2 2020 and held it in 15 quarters. The position peaked at $476K in Q4 2020. 197 funds tracked by Wall St. Rank hold IMVT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Immunovant position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,955 Immunovant shares in Q2 2024, an estimated $95.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Immunovant in Q2 2020 and held it in 15 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Immunovant position peaked at $476K in Q4 2020.
  • 197 funds tracked by Wall St. Rank held Immunovant as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.